Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.
The official print number for this legislation is 116_HCONRES_55.
This legislation was initiated in the House of Representatives.
The process officially started on 2019-07-24.
Key points include:
The current status is Expired.
The full official text is available at: View full text
The primary sponsor is Rep. Burgess, Michael C. [R-TX-26].
The latest detailed status is: Introduced in House
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-03.